HumanOptics AG: Person of Chinese investor now known as indirect majority shareholder of HumanOptics AG

HumanOptics AG / Key word(s): Miscellaneous
HumanOptics AG: Person of Chinese investor now known as indirect majority shareholder of HumanOptics AG

19-Dec-2019 / 19:04 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Person of Chinese investor now known as indirect majority shareholder of HumanOptics AG

Erlangen, 19 December 2019 - The Management Board of HumanOptics AG ("Company"), a leading technology company that manufactures implants for eye surgery, was informed today that the following companies are behind the Company's new majority shareholder - HumanOptics Holding AG, Berlin - and that the following Chinese private individual is at the end of the shareholding chain: Legend Medical Investment Ltd., Tortola, British Virgin Islands;
Legend Medical Investment (Hong Kong) Limited, Hong Kong; Hunan Liangjing Medical Management Co, Changsha, Hunan Province, China; Shanghai Qilin Medical Technology Co., Ltd, Shanghai, China; LI Lijuan, Shanghai, China.

Contact:

HumanOptics AG
Investor Relations
Spardorfer Str. 150
91054 Erlangen
Telefon: +49 (0) 9131 50665-0
E-Mail: IR@humanoptics.com

19-Dec-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de